Your search resulted in multiple matches. Please select a position:

Gencode Genes

CD7 (ENST00000312648.8) at chr17:82314873-82317608 - Homo sapiens CD7 molecule (CD7), mRNA. (from RefSeq NM_006137)
CD7 (ENST00000584284.5) at chr17:82314868-82317577 - The sequence shown here is derived from an Ensembl  automatic analysis pipeline and should be considered as  preliminary data. (from UniProt J3QLM0)
CD7 (ENST00000583376.1) at chr17:82314874-82317552 - The sequence shown here is derived from an Ensembl  automatic analysis pipeline and should be considered as  preliminary data. (from UniProt J3QLC7)
CD7 (ENST00000582480.1) at chr17:82316385-82317579 - The sequence shown here is derived from an Ensembl  automatic analysis pipeline and should be considered as  preliminary data. (from UniProt J3QRF1)
CD7 (ENST00000581744.1) at chr17:82316132-82317553 - CD7 molecule (from HGNC CD7)
CD7 (ENST00000581434.1) at chr17:82316220-82317550 - The sequence shown here is derived from an Ensembl  automatic analysis pipeline and should be considered as  preliminary data. (from UniProt J3QS65)
CD7 (ENST00000578509.1) at chr17:82315975-82317558 - The sequence shown here is derived from an Ensembl  automatic analysis pipeline and should be considered as  preliminary data. (from UniProt J3QS78)
SECTM1 (ENST00000269389.8) at chr17:82321024-82333766 - Homo sapiens secreted and transmembrane 1 (SECTM1), mRNA. (from RefSeq NM_003004)
LGALS1 (ENST00000215909.10) at chr22:37675636-37679802 - Homo sapiens galectin 1 (LGALS1), mRNA. (from RefSeq NM_002305)
CD74 (ENST00000009530.12) at chr5:150400041-150412751 - Homo sapiens CD74 molecule (CD74), transcript variant 1, mRNA. (from RefSeq NM_001025159)
CD72 (ENST00000396757.5) at chr9:35609533-35619542 - CD72 molecule (from HGNC CD72)
CD70 (ENST00000245903.4) at chr19:6585839-6591150 - Homo sapiens CD70 molecule (CD70), transcript variant 1, mRNA. (from RefSeq NM_001252)
CD74 (ENST00000524315.5) at chr5:150401864-150412751 - The sequence shown here is derived from an Ensembl  automatic analysis pipeline and should be considered as  preliminary data. (from UniProt E7ESL3)
CD74 (ENST00000523836.5) at chr5:150405978-150412751 - CD74 molecule (from HGNC CD74)
CD74 (ENST00000523813.1) at chr5:150405316-150412751 - The sequence shown here is derived from an Ensembl  automatic analysis pipeline and should be considered as  preliminary data. (from UniProt E7ER71)
CD74 (ENST00000523208.5) at chr5:150402170-150412739 - Homo sapiens CD74 molecule (CD74), transcript variant 6, non-coding RNA. (from RefSeq NR_157074)
CD74 (ENST00000522246.5) at chr5:150404664-150412751 - The sequence shown here is derived from an Ensembl  automatic analysis pipeline and should be considered as  preliminary data. (from UniProt E7EQJ3)
CD74 (ENST00000522153.1) at chr5:150406705-150412751 - CD74 molecule (from HGNC CD74)
CD74 (ENST00000518797.5) at chr5:150401699-150412732 - The sequence shown here is derived from an Ensembl  automatic analysis pipeline and should be considered as  preliminary data. (from UniProt H0YBZ2)
CD74 (ENST00000517791.1) at chr5:150406039-150412912 - CD74 molecule (from HGNC CD74)
CD74 (ENST00000517752.5) at chr5:150404486-150412746 - CD74 molecule (from HGNC CD74)
CD74 (ENST00000377795.7) at chr5:150401637-150412769 - Homo sapiens CD74 molecule (CD74), transcript variant 5, mRNA. (from RefSeq NM_001364084)
CD74 (ENST00000353334.10) at chr5:150401670-150412929 - Homo sapiens CD74 molecule (CD74), transcript variant 2, mRNA. (from RefSeq NM_004355)
CD72 (ENST00000612238.4) at chr9:35609979-35618811 - CD72 molecule (from HGNC CD72)
CD72 (ENST00000490239.5) at chr9:35609985-35618413 - CD72 molecule (from HGNC CD72)
CD72 (ENST00000482121.1) at chr9:35616894-35618376 - CD72 molecule (from HGNC CD72)
CD72 (ENST00000477364.5) at chr9:35615943-35618355 - CD72 molecule (from HGNC CD72)
CD72 (ENST00000470387.5) at chr9:35616566-35619534 - CD72 molecule (from HGNC CD72)
CD72 (ENST00000465754.6) at chr9:35616603-35646810 - CD72 molecule (from HGNC CD72)
CD72 (ENST00000463720.5) at chr9:35615943-35618353 - CD72 molecule (from HGNC CD72)
CD72 (ENST00000378431.5) at chr9:35616170-35618370 - CD72 molecule (from HGNC CD72)
CD72 (ENST00000378430.3) at chr9:35616939-35618389 - CD72 molecule (from HGNC CD72)
CD72 (ENST00000259633.8) at chr9:35609979-35618427 - Homo sapiens CD72 molecule (CD72), mRNA. (from RefSeq NM_001782)
CD70 (ENST00000597430.2) at chr19:6590103-6604103 - CD70 molecule (from HGNC CD70)
CD70 (ENST00000423145.7) at chr19:6583183-6591139 - Homo sapiens CD70 molecule (CD70), transcript variant 2, mRNA. (from RefSeq NM_001330332)
CD27 (ENST00000266557.3) at chr12:6444867-6451718 - Homo sapiens CD27 molecule (CD27), mRNA. (from RefSeq NM_001242)
ST6GAL1 (ENST00000457772.6) at chr3:186930526-187078553 - Homo sapiens ST6 beta-galactoside alpha-2,6-sialyltransferase 1 (ST6GAL1), transcript variant 3, mRNA. (from RefSeq NM_173217)
ST6GAL1 (ENST00000448044.5) at chr3:187021856-187078553 - Homo sapiens ST6 beta-galactoside alpha-2,6-sialyltransferase 1 (ST6GAL1), transcript variant 2, mRNA. (from RefSeq NM_003032)
ST6GAL1 (ENST00000169298.8) at chr3:186930526-187078553 - Homo sapiens ST6 beta-galactoside alpha-2,6-sialyltransferase 1 (ST6GAL1), transcript variant 1, mRNA. (from RefSeq NM_173216)
CD5 (ENST00000347785.8) at chr11:61102489-61127852 - Homo sapiens CD5 molecule (CD5), transcript variant 1, mRNA. (from RefSeq NM_014207)
CD1A (ENST00000289429.6) at chr1:158254424-158258269 - Homo sapiens CD1a molecule (CD1A), transcript variant 1, mRNA. (from RefSeq NM_001763)
HLA-DQB1 (ENST00000424806.1) at chr6_GL000253v2_alt:4076917-4086211 - Binds peptides derived from antigens that access the  endocytic route of antigen presenting cells (APC) and presents  them on the cell surface for recognition by the CD4 T-cells. The  peptide binding cleft accommodates peptides of 10-30 residues. The  peptides presented by MHC class II molecules are generated mostly  by degradation of proteins that access the endocytic route, where  they are processed by lysosomal proteases and other hydrolases.  Exogenous antigens that have been endocytosed by the APC are thus  readily available for presentation via MHC II molecules, and for  this reason this antigen presentation pathway is usually referred  to as exogenous. As membrane proteins on their way to degradation  in lysosomes as part of their normal turn-over are also contained  in the endosomal/lysosomal compartments, exogenous antigens must  compete with those derived from endogenous components. Autophagy  is also a source of endogenous peptides, autophagosomes  constitutively fuse with MHC class II loading compartments. In  addition to APCs, other cells of the gastrointestinal tract, such  as epithelial cells, express MHC class II molecules and CD74 and  act as APCs, which is an unusual trait of the GI tract. To produce  a MHC class II molecule that presents an antigen, three MHC class  II molecules (heterodimers of an alpha and a beta chain) associate  with a CD74 trimer in the ER to form a heterononamer. Soon after  the entry of this complex into the endosomal/lysosomal system  where antigen processing occurs, CD74 undergoes a sequential  degradation by various proteases, including CTSS and CTSL, leaving  a small fragment termed CLIP (class-II-associated invariant chain  peptide). The removal of CLIP is facilitated by HLA-DM via direct  binding to the alpha-beta-CLIP complex so that CLIP is released.  HLA-DM stabilizes MHC class II molecules until primary high  affinity antigenic peptides are bound. The MHC II molecule bound  to a peptide is then transported to the cell membrane surface. In  B-cells, the interaction between HLA-DM and MHC class II molecules  is regulated by HLA-DO. Primary dendritic cells (DCs) also to  express HLA-DO. Lysosomal miroenvironment has been implicated in  the regulation of antigen loading into MHC II molecules, increased  acidification produces increased proteolysis and efficient peptide  loading. (from UniProt P01920)
HLA-DRB1 (ENST00000328980.11) at chr6_GL000255v2_alt:3779004-3792428 - Binds peptides derived from antigens that access the  endocytic route of antigen presenting cells (APC) and presents  them on the cell surface for recognition by the CD4 T-cells. The  peptide binding cleft accommodates peptides of 10-30 residues. The  peptides presented by MHC class II molecules are generated mostly  by degradation of proteins that access the endocytic route, where  they are processed by lysosomal proteases and other hydrolases.  Exogenous antigens that have been endocytosed by the APC are thus  readily available for presentation via MHC II molecules, and for  this reason this antigen presentation pathway is usually referred  to as exogenous. As membrane proteins on their way to degradation  in lysosomes as part of their normal turn-over are also contained  in the endosomal/lysosomal compartments, exogenous antigens must  compete with those derived from endogenous components. Autophagy  is also a source of endogenous peptides, autophagosomes  constitutively fuse with MHC class II loading compartments. In  addition to APCs, other cells of the gastrointestinal tract, such  as epithelial cells, express MHC class II molecules and CD74 and  act as APCs, which is an unusual trait of the GI tract. To produce  a MHC class II molecule that presents an antigen, three MHC class  II molecules (heterodimers of an alpha and a beta chain) associate  with a CD74 trimer in the ER to form a heterononamer. Soon after  the entry of this complex into the endosomal/lysosomal system  where antigen processing occurs, CD74 undergoes a sequential  degradation by various proteases, including CTSS and CTSL, leaving  a small fragment termed CLIP (class-II-associated invariant chain  peptide). The removal of CLIP is facilitated by HLA-DM via direct  binding to the alpha-beta-CLIP complex so that CLIP is released.  HLA-DM stabilizes MHC class II molecules until primary high  affinity antigenic peptides are bound. The MHC II molecule bound  to a peptide is then transported to the cell membrane surface. In  B-cells, the interaction between HLA-DM and MHC class II molecules  is regulated by HLA-DO. Primary dendritic cells (DCs) also to  express HLA-DO. Lysosomal miroenvironment has been implicated in  the regulation of antigen loading into MHC II molecules, increased  acidification produces increased proteolysis and efficient peptide  loading. (from UniProt Q9GIY3)
HLA-DQA1 (ENST00000444296.6) at chr6_GL000256v2_alt:4039371-4045152 - Binds peptides derived from antigens that access the  endocytic route of antigen presenting cells (APC) and presents  them on the cell surface for recognition by the CD4 T-cells. The  peptide binding cleft accommodates peptides of 10-30 residues. The  peptides presented by MHC class II molecules are generated mostly  by degradation of proteins that access the endocytic route, where  they are processed by lysosomal proteases and other hydrolases.  Exogenous antigens that have been endocytosed by the APC are thus  readily available for presentation via MHC II molecules, and for  this reason this antigen presentation pathway is usually referred  to as exogenous. As membrane proteins on their way to degradation  in lysosomes as part of their normal turn-over are also contained  in the endosomal/lysosomal compartments, exogenous antigens must  compete with those derived from endogenous components. Autophagy  is also a source of endogenous peptides, autophagosomes  constitutively fuse with MHC class II loading compartments. In  addition to APCs, other cells of the gastrointestinal tract, such  as epithelial cells, express MHC class II molecules and CD74 and  act as APCs, which is an unusual trait of the GI tract. To produce  a MHC class II molecule that presents an antigen, three MHC class  II molecules (heterodimers of an alpha and a beta chain) associate  with a CD74 trimer in the ER to form a heterononamer. Soon after  the entry of this complex into the endosomal/lysosomal system  where antigen processing occurs, CD74 undergoes a sequential  degradation by various proteases, including CTSS and CTSL, leaving  a small fragment termed CLIP (class-II-associated invariant chain  peptide). The removal of CLIP is facilitated by HLA-DM via direct  binding to the alpha-beta-CLIP complex so that CLIP is released.  HLA-DM stabilizes MHC class II molecules until primary high  affinity antigenic peptides are bound. The MHC II molecule bound  to a peptide is then transported to the cell membrane surface. In  B-cells, the interaction between HLA-DM and MHC class II molecules  is regulated by HLA-DO. Primary dendritic cells (DCs) also to  express HLA-DO. Lysosomal miroenvironment has been implicated in  the regulation of antigen loading into MHC II molecules, increased  acidification produces increased proteolysis and efficient peptide  loading. (from UniProt P01909)
HLA-DQA1 (ENST00000395363.5) at chr6:32637401-32643652 - Binds peptides derived from antigens that access the  endocytic route of antigen presenting cells (APC) and presents  them on the cell surface for recognition by the CD4 T-cells. The  peptide binding cleft accommodates peptides of 10-30 residues. The  peptides presented by MHC class II molecules are generated mostly  by degradation of proteins that access the endocytic route, where  they are processed by lysosomal proteases and other hydrolases.  Exogenous antigens that have been endocytosed by the APC are thus  readily available for presentation via MHC II molecules, and for  this reason this antigen presentation pathway is usually referred  to as exogenous. As membrane proteins on their way to degradation  in lysosomes as part of their normal turn-over are also contained  in the endosomal/lysosomal compartments, exogenous antigens must  compete with those derived from endogenous components. Autophagy  is also a source of endogenous peptides, autophagosomes  constitutively fuse with MHC class II loading compartments. In  addition to APCs, other cells of the gastrointestinal tract, such  as epithelial cells, express MHC class II molecules and CD74 and  act as APCs, which is an unusual trait of the GI tract. To produce  a MHC class II molecule that presents an antigen, three MHC class  II molecules (heterodimers of an alpha and a beta chain) associate  with a CD74 trimer in the ER to form a heterononamer. Soon after  the entry of this complex into the endosomal/lysosomal system  where antigen processing occurs, CD74 undergoes a sequential  degradation by various proteases, including CTSS and CTSL, leaving  a small fragment termed CLIP (class-II-associated invariant chain  peptide). The removal of CLIP is facilitated by HLA-DM via direct  binding to the alpha-beta-CLIP complex so that CLIP is released.  HLA-DM stabilizes MHC class II molecules until primary high  affinity antigenic peptides are bound. The MHC II molecule bound  to a peptide is then transported to the cell membrane surface. In  B-cells, the interaction between HLA-DM and MHC class II molecules  is regulated by HLA-DO. Primary dendritic cells (DCs) also to  express HLA-DO. Lysosomal miroenvironment has been implicated in  the regulation of antigen loading into MHC II molecules, increased  acidification produces increased proteolysis and efficient peptide  loading. (from UniProt P01909)
HLA-DQA1 (ENST00000374949.2) at chr6:32637420-32643017 - Binds peptides derived from antigens that access the  endocytic route of antigen presenting cells (APC) and presents  them on the cell surface for recognition by the CD4 T-cells. The  peptide binding cleft accommodates peptides of 10-30 residues. The  peptides presented by MHC class II molecules are generated mostly  by degradation of proteins that access the endocytic route, where  they are processed by lysosomal proteases and other hydrolases.  Exogenous antigens that have been endocytosed by the APC are thus  readily available for presentation via MHC II molecules, and for  this reason this antigen presentation pathway is usually referred  to as exogenous. As membrane proteins on their way to degradation  in lysosomes as part of their normal turn-over are also contained  in the endosomal/lysosomal compartments, exogenous antigens must  compete with those derived from endogenous components. Autophagy  is also a source of endogenous peptides, autophagosomes  constitutively fuse with MHC class II loading compartments. In  addition to APCs, other cells of the gastrointestinal tract, such  as epithelial cells, express MHC class II molecules and CD74 and  act as APCs, which is an unusual trait of the GI tract. To produce  a MHC class II molecule that presents an antigen, three MHC class  II molecules (heterodimers of an alpha and a beta chain) associate  with a CD74 trimer in the ER to form a heterononamer. Soon after  the entry of this complex into the endosomal/lysosomal system  where antigen processing occurs, CD74 undergoes a sequential  degradation by various proteases, including CTSS and CTSL, leaving  a small fragment termed CLIP (class-II-associated invariant chain  peptide). The removal of CLIP is facilitated by HLA-DM via direct  binding to the alpha-beta-CLIP complex so that CLIP is released.  HLA-DM stabilizes MHC class II molecules until primary high  affinity antigenic peptides are bound. The MHC II molecule bound  to a peptide is then transported to the cell membrane surface. In  B-cells, the interaction between HLA-DM and MHC class II molecules  is regulated by HLA-DO. Primary dendritic cells (DCs) also to  express HLA-DO. Lysosomal miroenvironment has been implicated in  the regulation of antigen loading into MHC II molecules, increased  acidification produces increased proteolysis and efficient peptide  loading. (from UniProt P01909)
HLA-DRB1 (ENST00000428566.5) at chr6_GL000251v2_alt:4000478-4028652 - Binds peptides derived from antigens that access the  endocytic route of antigen presenting cells (APC) and presents  them on the cell surface for recognition by the CD4 T-cells. The  peptide binding cleft accommodates peptides of 10-30 residues. The  peptides presented by MHC class II molecules are generated mostly  by degradation of proteins that access the endocytic route, where  they are processed by lysosomal proteases and other hydrolases.  Exogenous antigens that have been endocytosed by the APC are thus  readily available for presentation via MHC II molecules, and for  this reason this antigen presentation pathway is usually referred  to as exogenous. As membrane proteins on their way to degradation  in lysosomes as part of their normal turn-over are also contained  in the endosomal/lysosomal compartments, exogenous antigens must  compete with those derived from endogenous components. Autophagy  is also a source of endogenous peptides, autophagosomes  constitutively fuse with MHC class II loading compartments. In  addition to APCs, other cells of the gastrointestinal tract, such  as epithelial cells, express MHC class II molecules and CD74 and  act as APCs, which is an unusual trait of the GI tract. To produce  a MHC class II molecule that presents an antigen, three MHC class  II molecules (heterodimers of an alpha and a beta chain) associate  with a CD74 trimer in the ER to form a heterononamer. Soon after  the entry of this complex into the endosomal/lysosomal system  where antigen processing occurs, CD74 undergoes a sequential  degradation by various proteases, including CTSS and CTSL, leaving  a small fragment termed CLIP (class-II-associated invariant chain  peptide). The removal of CLIP is facilitated by HLA-DM via direct  binding to the alpha-beta-CLIP complex so that CLIP is released.  HLA-DM stabilizes MHC class II molecules until primary high  affinity antigenic peptides are bound. The MHC II molecule bound  to a peptide is then transported to the cell membrane surface. In  B-cells, the interaction between HLA-DM and MHC class II molecules  is regulated by HLA-DO. Primary dendritic cells (DCs) also to  express HLA-DO. Lysosomal miroenvironment has been implicated in  the regulation of antigen loading into MHC II molecules, increased  acidification produces increased proteolysis and efficient peptide  loading. (from UniProt Q9GIY3)
HLA-DRB1 (ENST00000415796.5) at chr6_GL000255v2_alt:3781437-3809621 - Binds peptides derived from antigens that access the  endocytic route of antigen presenting cells (APC) and presents  them on the cell surface for recognition by the CD4 T-cells. The  peptide binding cleft accommodates peptides of 10-30 residues. The  peptides presented by MHC class II molecules are generated mostly  by degradation of proteins that access the endocytic route, where  they are processed by lysosomal proteases and other hydrolases.  Exogenous antigens that have been endocytosed by the APC are thus  readily available for presentation via MHC II molecules, and for  this reason this antigen presentation pathway is usually referred  to as exogenous. As membrane proteins on their way to degradation  in lysosomes as part of their normal turn-over are also contained  in the endosomal/lysosomal compartments, exogenous antigens must  compete with those derived from endogenous components. Autophagy  is also a source of endogenous peptides, autophagosomes  constitutively fuse with MHC class II loading compartments. In  addition to APCs, other cells of the gastrointestinal tract, such  as epithelial cells, express MHC class II molecules and CD74 and  act as APCs, which is an unusual trait of the GI tract. To produce  a MHC class II molecule that presents an antigen, three MHC class  II molecules (heterodimers of an alpha and a beta chain) associate  with a CD74 trimer in the ER to form a heterononamer. Soon after  the entry of this complex into the endosomal/lysosomal system  where antigen processing occurs, CD74 undergoes a sequential  degradation by various proteases, including CTSS and CTSL, leaving  a small fragment termed CLIP (class-II-associated invariant chain  peptide). The removal of CLIP is facilitated by HLA-DM via direct  binding to the alpha-beta-CLIP complex so that CLIP is released.  HLA-DM stabilizes MHC class II molecules until primary high  affinity antigenic peptides are bound. The MHC II molecule bound  to a peptide is then transported to the cell membrane surface. In  B-cells, the interaction between HLA-DM and MHC class II molecules  is regulated by HLA-DO. Primary dendritic cells (DCs) also to  express HLA-DO. Lysosomal miroenvironment has been implicated in  the regulation of antigen loading into MHC II molecules, increased  acidification produces increased proteolysis and efficient peptide  loading. (from UniProt Q9GIY3)
HLA-DQA1 (ENST00000399678.5) at chr6_GL000255v2_alt:3836468-3842664 - Binds peptides derived from antigens that access the  endocytic route of antigen presenting cells (APC) and presents  them on the cell surface for recognition by the CD4 T-cells. The  peptide binding cleft accommodates peptides of 10-30 residues. The  peptides presented by MHC class II molecules are generated mostly  by degradation of proteins that access the endocytic route, where  they are processed by lysosomal proteases and other hydrolases.  Exogenous antigens that have been endocytosed by the APC are thus  readily available for presentation via MHC II molecules, and for  this reason this antigen presentation pathway is usually referred  to as exogenous. As membrane proteins on their way to degradation  in lysosomes as part of their normal turn-over are also contained  in the endosomal/lysosomal compartments, exogenous antigens must  compete with those derived from endogenous components. Autophagy  is also a source of endogenous peptides, autophagosomes  constitutively fuse with MHC class II loading compartments. In  addition to APCs, other cells of the gastrointestinal tract, such  as epithelial cells, express MHC class II molecules and CD74 and  act as APCs, which is an unusual trait of the GI tract. To produce  a MHC class II molecule that presents an antigen, three MHC class  II molecules (heterodimers of an alpha and a beta chain) associate  with a CD74 trimer in the ER to form a heterononamer. Soon after  the entry of this complex into the endosomal/lysosomal system  where antigen processing occurs, CD74 undergoes a sequential  degradation by various proteases, including CTSS and CTSL, leaving  a small fragment termed CLIP (class-II-associated invariant chain  peptide). The removal of CLIP is facilitated by HLA-DM via direct  binding to the alpha-beta-CLIP complex so that CLIP is released.  HLA-DM stabilizes MHC class II molecules until primary high  affinity antigenic peptides are bound. The MHC II molecule bound  to a peptide is then transported to the cell membrane surface. In  B-cells, the interaction between HLA-DM and MHC class II molecules  is regulated by HLA-DO. Primary dendritic cells (DCs) also to  express HLA-DO. Lysosomal miroenvironment has been implicated in  the regulation of antigen loading into MHC II molecules, increased  acidification produces increased proteolysis and efficient peptide  loading. (from UniProt P01909)
HLA-DQA1 (ENST00000399675.5) at chr6_GL000255v2_alt:3836468-3842664 - Binds peptides derived from antigens that access the  endocytic route of antigen presenting cells (APC) and presents  them on the cell surface for recognition by the CD4 T-cells. The  peptide binding cleft accommodates peptides of 10-30 residues. The  peptides presented by MHC class II molecules are generated mostly  by degradation of proteins that access the endocytic route, where  they are processed by lysosomal proteases and other hydrolases.  Exogenous antigens that have been endocytosed by the APC are thus  readily available for presentation via MHC II molecules, and for  this reason this antigen presentation pathway is usually referred  to as exogenous. As membrane proteins on their way to degradation  in lysosomes as part of their normal turn-over are also contained  in the endosomal/lysosomal compartments, exogenous antigens must  compete with those derived from endogenous components. Autophagy  is also a source of endogenous peptides, autophagosomes  constitutively fuse with MHC class II loading compartments. In  addition to APCs, other cells of the gastrointestinal tract, such  as epithelial cells, express MHC class II molecules and CD74 and  act as APCs, which is an unusual trait of the GI tract. To produce  a MHC class II molecule that presents an antigen, three MHC class  II molecules (heterodimers of an alpha and a beta chain) associate  with a CD74 trimer in the ER to form a heterononamer. Soon after  the entry of this complex into the endosomal/lysosomal system  where antigen processing occurs, CD74 undergoes a sequential  degradation by various proteases, including CTSS and CTSL, leaving  a small fragment termed CLIP (class-II-associated invariant chain  peptide). The removal of CLIP is facilitated by HLA-DM via direct  binding to the alpha-beta-CLIP complex so that CLIP is released.  HLA-DM stabilizes MHC class II molecules until primary high  affinity antigenic peptides are bound. The MHC II molecule bound  to a peptide is then transported to the cell membrane surface. In  B-cells, the interaction between HLA-DM and MHC class II molecules  is regulated by HLA-DO. Primary dendritic cells (DCs) also to  express HLA-DO. Lysosomal miroenvironment has been implicated in  the regulation of antigen loading into MHC II molecules, increased  acidification produces increased proteolysis and efficient peptide  loading. (from UniProt P01909)
HLA-DRB1 (ENST00000412634.5) at chr6_GL000256v2_alt:3981401-4012352 - Binds peptides derived from antigens that access the  endocytic route of antigen presenting cells (APC) and presents  them on the cell surface for recognition by the CD4 T-cells. The  peptide binding cleft accommodates peptides of 10-30 residues. The  peptides presented by MHC class II molecules are generated mostly  by degradation of proteins that access the endocytic route, where  they are processed by lysosomal proteases and other hydrolases.  Exogenous antigens that have been endocytosed by the APC are thus  readily available for presentation via MHC II molecules, and for  this reason this antigen presentation pathway is usually referred  to as exogenous. As membrane proteins on their way to degradation  in lysosomes as part of their normal turn-over are also contained  in the endosomal/lysosomal compartments, exogenous antigens must  compete with those derived from endogenous components. Autophagy  is also a source of endogenous peptides, autophagosomes  constitutively fuse with MHC class II loading compartments. In  addition to APCs, other cells of the gastrointestinal tract, such  as epithelial cells, express MHC class II molecules and CD74 and  act as APCs, which is an unusual trait of the GI tract. To produce  a MHC class II molecule that presents an antigen, three MHC class  II molecules (heterodimers of an alpha and a beta chain) associate  with a CD74 trimer in the ER to form a heterononamer. Soon after  the entry of this complex into the endosomal/lysosomal system  where antigen processing occurs, CD74 undergoes a sequential  degradation by various proteases, including CTSS and CTSL, leaving  a small fragment termed CLIP (class-II-associated invariant chain  peptide). The removal of CLIP is facilitated by HLA-DM via direct  binding to the alpha-beta-CLIP complex so that CLIP is released.  HLA-DM stabilizes MHC class II molecules until primary high  affinity antigenic peptides are bound. The MHC II molecule bound  to a peptide is then transported to the cell membrane surface. In  B-cells, the interaction between HLA-DM and MHC class II molecules  is regulated by HLA-DO. Primary dendritic cells (DCs) also to  express HLA-DO. Lysosomal miroenvironment has been implicated in  the regulation of antigen loading into MHC II molecules, increased  acidification produces increased proteolysis and efficient peptide  loading. (from UniProt Q9GIY3)
MIF (ENST00000613839.2) at chr22_KI270879v1_alt:130366-131588 - Homo sapiens macrophage migration inhibitory factor (MIF), mRNA. (from RefSeq NM_002415)
MIF (ENST00000215754.8) at chr22:23894383-23895223 - Homo sapiens macrophage migration inhibitory factor (MIF), mRNA. (from RefSeq NM_002415)
HLA-DQB2 (ENST00000430849.6) at chr6_GL000252v2_alt:4000854-4008293 - Homo sapiens major histocompatibility complex, class II, DQ beta 2 (HLA-DQB2), transcript variant 1, mRNA. (from RefSeq NM_001300790)
HLA-DQB2 (ENST00000457432.6) at chr6_GL000253v2_alt:4175450-4182889 - Homo sapiens major histocompatibility complex, class II, DQ beta 2 (HLA-DQB2), transcript variant 1, mRNA. (from RefSeq NM_001300790)
HLA-DQB2 (ENST00000432486.6) at chr6_GL000254v2_alt:4055473-4062912 - Homo sapiens major histocompatibility complex, class II, DQ beta 2 (HLA-DQB2), transcript variant 1, mRNA. (from RefSeq NM_001300790)
HLA-DQB2 (ENST00000399661.4) at chr6_GL000255v2_alt:3950399-3957838 - Homo sapiens major histocompatibility complex, class II, DQ beta 2 (HLA-DQB2), transcript variant 1, mRNA. (from RefSeq NM_001300790)
HLA-DQB2 (ENST00000456529.1) at chr6_GL000250v2_alt:4062237-4069630 - Homo sapiens major histocompatibility complex, class II, DQ beta 2 (HLA-DQB2), transcript variant 2, mRNA. (from RefSeq NM_001198858)
HLA-DQB2 (ENST00000438757.1) at chr6_GL000251v2_alt:4169671-4177064 - Homo sapiens major histocompatibility complex, class II, DQ beta 2 (HLA-DQB2), transcript variant 2, mRNA. (from RefSeq NM_001198858)
HLA-DQB2 (ENST00000426733.5) at chr6_GL000256v2_alt:4156243-4163635 - Homo sapiens major histocompatibility complex, class II, DQ beta 2 (HLA-DQB2), transcript variant 2, mRNA. (from RefSeq NM_001198858)
HLA-DQB2 (ENST00000411527.5) at chr6:32756098-32763490 - Homo sapiens major histocompatibility complex, class II, DQ beta 2 (HLA-DQB2), transcript variant 2, mRNA. (from RefSeq NM_001198858)
HLA-DQA2 (ENST00000453672.2) at chr6_GL000253v2_alt:4160657-4166218 - Homo sapiens major histocompatibility complex, class II, DQ alpha 2 (HLA-DQA2), mRNA. (from RefSeq NM_020056)
HLA-DQA2 (ENST00000446482.2) at chr6_GL000255v2_alt:3935606-3941465 - Homo sapiens major histocompatibility complex, class II, DQ alpha 2 (HLA-DQA2), mRNA. (from RefSeq NM_020056)
HLA-DQA2 (ENST00000241802.9) at chr6_GL000254v2_alt:4040716-4046584 - Homo sapiens major histocompatibility complex, class II, DQ alpha 2 (HLA-DQA2), mRNA. (from RefSeq NM_020056)
HLA-DQA2 (ENST00000415898.2) at chr6_GL000256v2_alt:4141489-4147359 - Homo sapiens major histocompatibility complex, class II, DQ alpha 2 (HLA-DQA2), mRNA. (from RefSeq NM_020056)
HLA-DRA (ENST00000383127.6) at chr6_GL000251v2_alt:3877968-3883135 - Homo sapiens major histocompatibility complex, class II, DR alpha (HLA-DRA), mRNA. (from RefSeq NM_019111)
HLA-DRA (ENST00000416883.6) at chr6_GL000252v2_alt:3680147-3685357 - Homo sapiens major histocompatibility complex, class II, DR alpha (HLA-DRA), mRNA. (from RefSeq NM_019111)
HLA-DRA (ENST00000442960.6) at chr6_GL000253v2_alt:3744059-3749270 - Homo sapiens major histocompatibility complex, class II, DR alpha (HLA-DRA), mRNA. (from RefSeq NM_019111)
HLA-DRA (ENST00000414698.6) at chr6_GL000254v2_alt:3780808-3786018 - Homo sapiens major histocompatibility complex, class II, DR alpha (HLA-DRA), mRNA. (from RefSeq NM_019111)
HLA-DRA (ENST00000383259.6) at chr6_GL000255v2_alt:3662891-3668101 - Homo sapiens major histocompatibility complex, class II, DR alpha (HLA-DRA), mRNA. (from RefSeq NM_019111)
HLA-DRA (ENST00000411524.6) at chr6_GL000256v2_alt:3754985-3760195 - Homo sapiens major histocompatibility complex, class II, DR alpha (HLA-DRA), mRNA. (from RefSeq NM_019111)
HLA-DRA (ENST00000395388.7) at chr6:32439887-32445046 - Homo sapiens major histocompatibility complex, class II, DR alpha (HLA-DRA), mRNA. (from RefSeq NM_019111)
HLA-DRB1 (ENST00000444645.6) at chr6_GL000252v2_alt:3814543-3830112 - Homo sapiens major histocompatibility complex, class II, DR beta 1 (HLA-DRB1), transcript variant 3, mRNA. (from RefSeq NM_001359193)
HLA-DRB1 (ENST00000437784.6) at chr6_GL000253v2_alt:3988943-4004557 - Homo sapiens major histocompatibility complex, class II, DR beta 1 (HLA-DRB1), transcript variant 3, mRNA. (from RefSeq NM_001359193)
ROS1 (ENST00000368508.7) at chr6:117288300-117425855 - Homo sapiens ROS proto-oncogene 1, receptor tyrosine kinase (ROS1), mRNA. (from RefSeq NM_002944)
HLA-DRB4 (ENST00000411565.2) at chr6_GL000256v2_alt:3851133-3866096 - Homo sapiens major histocompatibility complex, class II, DR beta 4 (HLA-DRB4), mRNA. (from RefSeq NM_021983)
HLA-DQA1 (ENST00000418023.5) at chr6_GL000256v2_alt:4039288-4045152 - Homo sapiens major histocompatibility complex, class II, DQ alpha 1 (HLA-DQA1), mRNA. (from RefSeq NM_002122)
HLA-DQA1 (ENST00000383251.6) at chr6_GL000255v2_alt:3836385-3842664 - Homo sapiens major histocompatibility complex, class II, DQ alpha 1 (HLA-DQA1), mRNA. (from RefSeq NM_002122)
HLA-DQA1 (ENST00000343139.10) at chr6:32637406-32643671 - Homo sapiens major histocompatibility complex, class II, DQ alpha 1 (HLA-DQA1), mRNA. (from RefSeq NM_002122)
HLA-DQB1 (ENST00000419914.6) at chr6_GL000253v2_alt:4076917-4084516 - Homo sapiens major histocompatibility complex, class II, DQ beta 1 (HLA-DQB1), transcript variant 3, mRNA. (from RefSeq NM_001243962)
HLA-DRB5 (ENST00000374975.4) at chr6:32517353-32530287 - Homo sapiens major histocompatibility complex, class II, DR beta 5 (HLA-DRB5), mRNA. (from RefSeq NM_002125)
HLA-DRB3 (ENST00000383126.7) at chr6_GL000251v2_alt:3934009-3947126 - Homo sapiens major histocompatibility complex, class II, DR beta 3 (HLA-DRB3), mRNA. (from RefSeq NM_022555)
HLA-DRB3 (ENST00000307137.11) at chr6_GL000255v2_alt:3715358-3728445 - Homo sapiens major histocompatibility complex, class II, DR beta 3 (HLA-DRB3), mRNA. (from RefSeq NM_022555)
HLA-DRB1 (ENST00000399450.6) at chr6_GL000251v2_alt:3998045-4011459 - Homo sapiens major histocompatibility complex, class II, DR beta 1 (HLA-DRB1), transcript variant 2, mRNA. (from RefSeq NM_001243965)
HLA-DRB1 (ENST00000419393.6) at chr6_GL000256v2_alt:3979128-3993834 - Homo sapiens major histocompatibility complex, class II, DR beta 1 (HLA-DRB1), transcript variant 4, mRNA. (from RefSeq NM_001359194)
HLA-DPB1 (ENST00000454006.6) at chr6_GL000252v2_alt:4319457-4330724 - Homo sapiens major histocompatibility complex, class II, DP beta 1 (HLA-DPB1), mRNA. (from RefSeq NM_002121)
HLA-DPB1 (ENST00000399500.6) at chr6_GL000255v2_alt:4270558-4281835 - Homo sapiens major histocompatibility complex, class II, DP beta 1 (HLA-DPB1), mRNA. (from RefSeq NM_002121)
HLA-DPB1 (ENST00000433800.6) at chr6_GL000256v2_alt:4524909-4536184 - Homo sapiens major histocompatibility complex, class II, DP beta 1 (HLA-DPB1), mRNA. (from RefSeq NM_002121)
HLA-DPB1 (ENST00000418931.7) at chr6:33075990-33089696 - Homo sapiens major histocompatibility complex, class II, DP beta 1 (HLA-DPB1), mRNA. (from RefSeq NM_002121)
CD79B (ENST00000006750.7) at chr17:63928740-63932354 - Homo sapiens CD79b molecule (CD79B), transcript variant 1, mRNA. (from RefSeq NM_000626)
CD79A (ENST00000221972.7) at chr19:41877120-41881372 - Homo sapiens CD79a molecule (CD79A), transcript variant 1, mRNA. (from RefSeq NM_001783)
CD79B (ENST00000583260.1) at chr17:63931891-63932323 - CD79b molecule (from HGNC CD79B)
CD79B (ENST00000559358.1) at chr17:63928768-63930514 - CD79b molecule (from HGNC CD79B)
CD79B (ENST00000558969.1) at chr17:63930960-63932331 - CD79b molecule (from HGNC CD79B)
CD79B (ENST00000392795.7) at chr17:63928740-63932336 - Homo sapiens CD79b molecule (CD79B), transcript variant 3, mRNA. (from RefSeq NM_001039933)
CD79B (ENST00000349817.2) at chr17:63929226-63932261 - Homo sapiens CD79b molecule (CD79B), transcript variant 2, mRNA. (from RefSeq NM_021602)
CD79A (ENST00000597454.1) at chr19:41877280-41880702 - CD79a molecule (from HGNC CD79A)
CD79A (ENST00000444740.2) at chr19:41877305-41880980 - Homo sapiens CD79a molecule (CD79A), transcript variant 2, mRNA. (from RefSeq NM_021601)
IGBP1P3 (ENST00000447449.1) at chr3:32620903-32621902 - immunoglobulin (CD79A) binding protein 1 pseudogene 3 (from HGNC IGBP1P3)
IGBP1P5 (ENST00000507524.1) at chr4:27585145-27586144 - immunoglobulin (CD79A) binding protein 1 pseudogene 5 (from HGNC IGBP1P5)
IGBP1P4 (ENST00000503202.1) at chr4:82401578-82402456 - immunoglobulin (CD79A) binding protein 1 pseudogene 4 (from HGNC IGBP1P4)
IGBP1P1 (ENST00000554337.1) at chr14:34939324-34940332 - immunoglobulin (CD79A) binding protein 1 pseudogene 1 (from HGNC IGBP1P1)
IGHD (ENST00000613640.1) at chr14:105838401-105845678 - IgD is the major antigen receptor isotype on the surface  of most peripheral B-cells, where it is coexpressed with IgM. The  membrane-bound IgD (mIgD) induces the phosphorylation of CD79A and  CD79B by the Src family of protein tyrosine kinases. Soluble IgD  (sIgD) concentration in serum below those of IgG, IgA, and IgM but  much higher than that of IgE. IgM and IgD molecules present on B  cells have identical V regions and antigen-binding sites. After  the antigen binds to the B-cell receptor, the secreted form sIgD  is shut off. IgD is a potent inducer of TNF, IL1B, and IL1RN. IgD  also induces release of IL6, IL10, and LIF from peripheral blood  mononuclear cells. Monocytes seem to be the main producers of  cytokines in vitro in the presence of IgD. (from UniProt P01880)
IGHM (ENST00000637539.2) at chr14:105851705-105856218 - IgM antibodies play an important role in primary defense  mechanisms. They have been shown to be involved in early  recognition of external invaders like bacteria and viruses,  cellular waste and modified self, as well as in recognition and  elimination of precancerous and cancerous lesions. The membrane-  bound form is found in the majority of normal B-cells alongside  with IgD. Membrane-bound IgM induces the phosphorylation of CD79A  and CD79B by the Src family of protein tyrosine kinases. It may  cause death of cells by apoptosis. It is also found in soluble  form, which represents about 30% of the total serum  immunoglobulins where it is found almost exclusively as an  homopentamer. After the antigen binds to the B-cell receptor, the  secreted form is secreted in large amounts. (from UniProt P01871)
IGHM (ENST00000626472.2) at chr14_KI270846v1_alt:321989-323987 - IgM antibodies play an important role in primary defense  mechanisms. They have been shown to be involved in early  recognition of external invaders like bacteria and viruses,  cellular waste and modified self, as well as in recognition and  elimination of precancerous and cancerous lesions. The membrane-  bound form is found in the majority of normal B-cells alongside  with IgD. Membrane-bound IgM induces the phosphorylation of CD79A  and CD79B by the Src family of protein tyrosine kinases. It may  cause death of cells by apoptosis. It is also found in soluble  form, which represents about 30% of the total serum  immunoglobulins where it is found almost exclusively as an  homopentamer. After the antigen binds to the B-cell receptor, the  secreted form is secreted in large amounts. (from UniProt P01871)
IGHM (ENST00000390559.6) at chr14:105854220-105856218 - IgM antibodies play an important role in primary defense  mechanisms. They have been shown to be involved in early  recognition of external invaders like bacteria and viruses,  cellular waste and modified self, as well as in recognition and  elimination of precancerous and cancerous lesions. The membrane-  bound form is found in the majority of normal B-cells alongside  with IgD. Membrane-bound IgM induces the phosphorylation of CD79A  and CD79B by the Src family of protein tyrosine kinases. It may  cause death of cells by apoptosis. It is also found in soluble  form, which represents about 30% of the total serum  immunoglobulins where it is found almost exclusively as an  homopentamer. After the antigen binds to the B-cell receptor, the  secreted form is secreted in large amounts. (from UniProt P01871)
LYN (ENST00000520220.6) at chr8:55879835-56014168 - Homo sapiens LYN proto-oncogene, Src family tyrosine kinase (LYN), transcript variant 2, mRNA. (from RefSeq NM_001111097)
LYN (ENST00000519728.6) at chr8:55879835-56014169 - Homo sapiens LYN proto-oncogene, Src family tyrosine kinase (LYN), transcript variant 1, mRNA. (from RefSeq NM_002350)
BLK (ENST00000259089.9) at chr8:11494387-11564599 - Homo sapiens BLK proto-oncogene, Src family tyrosine kinase (BLK), transcript variant 1, mRNA. (from RefSeq NM_001715)
BLNK (ENST00000224337.9) at chr10:96191702-96271540 - Homo sapiens B cell linker (BLNK), transcript variant 6, non-coding RNA. (from RefSeq NR_047680)
BLNK (ENST00000413476.6) at chr10:96191707-96271516 - Homo sapiens B cell linker (BLNK), transcript variant 9, non-coding RNA. (from RefSeq NR_047683)
BLNK (ENST00000371176.6) at chr10:96191702-96271540 - Homo sapiens B cell linker (BLNK), transcript variant 8, non-coding RNA. (from RefSeq NR_047682)
FYN (ENST00000368682.7) at chr6:111660332-111873067 - Homo sapiens FYN proto-oncogene, Src family tyrosine kinase (FYN), transcript variant 2, mRNA. (from RefSeq NM_153047)
FYN (ENST00000354650.7) at chr6:111660332-111873452 - Homo sapiens FYN proto-oncogene, Src family tyrosine kinase (FYN), transcript variant 1, mRNA. (from RefSeq NM_002037)
FYN (ENST00000229471.8) at chr6:111661282-111759131 - Homo sapiens FYN proto-oncogene, Src family tyrosine kinase (FYN), transcript variant 3, mRNA. (from RefSeq NM_153048)
FYN (ENST00000368667.6) at chr6:111661282-111793886 - Homo sapiens FYN proto-oncogene, Src family tyrosine kinase (FYN), transcript variant 4, mRNA. (from RefSeq NM_001370529)
FYN (ENST00000368678.8) at chr6:111661286-111873430 - Non-receptor tyrosine-protein kinase that plays a role  in many biological processes including regulation of cell growth  and survival, cell adhesion, integrin-mediated signaling,  cytoskeletal remodeling, cell motility, immune response and axon  guidance. Inactive FYN is phosphorylated on its C-terminal tail  within the catalytic domain. Following activation by PKA, the  protein subsequently associates with PTK2/FAK1, allowing PTK2/FAK1  phosphorylation, activation and targeting to focal adhesions.  Involved in the regulation of cell adhesion and motility through  phosphorylation of CTNNB1 (beta-catenin) and CTNND1 (delta-  catenin). Regulates cytoskeletal remodeling by phosphorylating  several proteins including the actin regulator WAS and the  microtubule-associated proteins MAP2 and MAPT. Promotes cell  survival by phosphorylating AGAP2/PIKE-A and preventing its  apoptotic cleavage. Participates in signal transduction pathways  that regulate the integrity of the glomerular slit diaphragm (an  essential part of the glomerular filter of the kidney) by  phosphorylating several slit diaphragm components including NPHS1,  KIRREL and TRPC6. Plays a role in neural processes by  phosphorylating DPYSL2, a multifunctional adapter protein within  the central nervous system, ARHGAP32, a regulator for Rho family  GTPases implicated in various neural functions, and SNCA, a small  pre-synaptic protein. Participates in the downstream signaling  pathways that lead to T-cell differentiation and proliferation  following T-cell receptor (TCR) stimulation. Also participates in  negative feedback regulation of TCR signaling through  phosphorylation of PAG1, thereby promoting interaction between  PAG1 and CSK and recruitment of CSK to lipid rafts. CSK maintains  LCK and FYN in an inactive form. Promotes CD28-induced  phosphorylation of VAV1. (from UniProt P06241)
FYN (ENST00000538466.5) at chr6:111660332-111720062 - Non-receptor tyrosine-protein kinase that plays a role  in many biological processes including regulation of cell growth  and survival, cell adhesion, integrin-mediated signaling,  cytoskeletal remodeling, cell motility, immune response and axon  guidance. Inactive FYN is phosphorylated on its C-terminal tail  within the catalytic domain. Following activation by PKA, the  protein subsequently associates with PTK2/FAK1, allowing PTK2/FAK1  phosphorylation, activation and targeting to focal adhesions.  Involved in the regulation of cell adhesion and motility through  phosphorylation of CTNNB1 (beta-catenin) and CTNND1 (delta-  catenin). Regulates cytoskeletal remodeling by phosphorylating  several proteins including the actin regulator WAS and the  microtubule-associated proteins MAP2 and MAPT. Promotes cell  survival by phosphorylating AGAP2/PIKE-A and preventing its  apoptotic cleavage. Participates in signal transduction pathways  that regulate the integrity of the glomerular slit diaphragm (an  essential part of the glomerular filter of the kidney) by  phosphorylating several slit diaphragm components including NPHS1,  KIRREL and TRPC6. Plays a role in neural processes by  phosphorylating DPYSL2, a multifunctional adapter protein within  the central nervous system, ARHGAP32, a regulator for Rho family  GTPases implicated in various neural functions, and SNCA, a small  pre-synaptic protein. Participates in the downstream signaling  pathways that lead to T-cell differentiation and proliferation  following T-cell receptor (TCR) stimulation. Also participates in  negative feedback regulation of TCR signaling through  phosphorylation of PAG1, thereby promoting interaction between  PAG1 and CSK and recruitment of CSK to lipid rafts. CSK maintains  LCK and FYN in an inactive form. Promotes CD28-induced  phosphorylation of VAV1. (from UniProt P06241)
SYK (ENST00000375751.8) at chr9:90801787-90898549 - Homo sapiens spleen associated tyrosine kinase (SYK), transcript variant 4, mRNA. (from RefSeq NM_001174168)
SYK (ENST00000375746.1) at chr9:90827488-90898549 - Homo sapiens spleen associated tyrosine kinase (SYK), transcript variant 3, mRNA. (from RefSeq NM_001174167)
SYK (ENST00000375754.9) at chr9:90801819-90898549 - Homo sapiens spleen associated tyrosine kinase (SYK), transcript variant 1, mRNA. (from RefSeq NM_003177)
SYK (ENST00000375747.5) at chr9:90801927-90898549 - Non-receptor tyrosine kinase which mediates signal  transduction downstream of a variety of transmembrane receptors  including classical immunoreceptors like the B-cell receptor  (BCR). Regulates several biological processes including innate and  adaptive immunity, cell adhesion, osteoclast maturation, platelet  activation and vascular development. Assembles into signaling  complexes with activated receptors at the plasma membrane via  interaction between its SH2 domains and the receptor tyrosine-  phosphorylated ITAM domains. The association with the receptor can  also be indirect and mediated by adapter proteins containing ITAM  or partial hemITAM domains. The phosphorylation of the ITAM  domains is generally mediated by SRC subfamily kinases upon  engagement of the receptor. More rarely signal transduction via  SYK could be ITAM-independent. Direct downstream effectors  phosphorylated by SYK include VAV1, PLCG1, PI-3-kinase, LCP2 and  BLNK. Initially identified as essential in B-cell receptor (BCR)  signaling, it is necessary for the maturation of B-cells most  probably at the pro-B to pre-B transition. Activated upon BCR  engagement, it phosphorylates and activates BLNK an adapter  linking the activated BCR to downstream signaling adapters and  effectors. It also phosphorylates and activates PLCG1 and the PKC  signaling pathway. It also phosphorylates BTK and regulates its  activity in B-cell antigen receptor (BCR)-coupled signaling.  Beside its function downstream of BCR plays also a role in T-cell  receptor signaling. Plays also a crucial role in the innate immune  response to fungal, bacterial and viral pathogens. It is for  instance activated by the membrane lectin CLEC7A. Upon stimulation  by fungal proteins, CLEC7A together with SYK activates immune  cells inducing the production of ROS. Also activates the  inflammasome and NF-kappa-B-mediated transcription of chemokines  and cytokines in presence of pathogens. Regulates neutrophil  degranulation and phagocytosis through activation of the MAPK  signaling cascade. Also mediates the activation of dendritic cells  by cell necrosis stimuli. Also involved in mast cells activation.  Also functions downstream of receptors mediating cell adhesion.  Relays for instance, integrin-mediated neutrophils and macrophages  activation and P-selectin receptor/SELPG-mediated recruitment of  leukocytes to inflammatory loci. Plays also a role in non-immune  processes. It is for instance involved in vascular development  where it may regulate blood and lymphatic vascular separation. It  is also required for osteoclast development and function.  Functions in the activation of platelets by collagen, mediating  PLCG2 phosphorylation and activation. May be coupled to the  collagen receptor by the ITAM domain-containing FCER1G. Also  activated by the membrane lectin CLEC1B that is required for  activation of platelets by PDPN/podoplanin. Involved in platelet  adhesion being activated by ITGB3 engaged by fibrinogen. (from UniProt P43405)

NCBI RefSeq genes, curated subset (NM_*, NR_*, NP_* or YP_*)

NM_006137.6 at chr17:82314870-82317604
NM_001330332.1 at chr19:6581646-6591152
NM_001252.4 at chr19:6585839-6591152
NM_001782.2 at chr9:35609979-35618427
NM_001025159.2 at chr5:150401637-150412936
NM_004355.3 at chr5:150401637-150412936
NM_001025158.2 at chr5:150401637-150412936
NM_021601.3 at chr19:41877120-41881372
NM_001783.3 at chr19:41877120-41881372
NM_001039933.2 at chr17:63928736-63932354
NM_001329050.1 at chr17:63928736-63932354
NM_000626.3 at chr17:63928736-63932354
NM_021602.3 at chr17:63928736-63932354

NCBI RefSeq genes, predicted subset (XM_* or XR_*)

XM_011523608.1 at chr17:82314865-82317541
XM_017025316.1 at chr17:82314865-82317579
XR_001752681.1 at chr17:82314865-82320829
XR_001752680.1 at chr17:82316385-82320829
XM_006716893.2 at chr9:35609981-35618427
XR_002956198.1 at chr5:150401637-150412756
XM_017010089.2 at chr5:150401637-150412756
XM_017010090.2 at chr5:150401637-150412756

NCBI RefSeq and Ensembl transcripts from the MANE Project (v0.6)

CD7 at chr17:82314873-82317608
CD70 at chr19:6585839-6591150

RefSeq Genes

CD74 at chr5:150400041-150412756 - (NR_157074) 
CD74 at chr5:150401637-150412936 - (NM_004355) HLA class II histocompatibility antigen gamma chain isoform b
CD74 at chr5:150401637-150412936 - (NM_001025159) HLA class II histocompatibility antigen gamma chain isoform a
CD74 at chr5:150401637-150412936 - (NM_001025158) HLA class II histocompatibility antigen gamma chain isoform c
CD74 at chr5:150400041-150412756 - (NM_001364084) HLA class II histocompatibility antigen gamma chain isoform e
CD74 at chr5:150400041-150412756 - (NM_001364083) HLA class II histocompatibility antigen gamma chain isoform d
CD79A at chr19:41877279-41881372 - (NM_021601) B-cell antigen receptor complex-associated protein alpha chain isoform 2 precursor
CD79A at chr19:41877279-41881372 - (NM_001783) B-cell antigen receptor complex-associated protein alpha chain isoform 1 precursor
CD79B at chr17:63928740-63932331 - (NM_021602) B-cell antigen receptor complex-associated protein beta chain isoform 2 precursor
CD79B at chr17:63928740-63932331 - (NM_001329050) B-cell antigen receptor complex-associated protein beta chain isoform 4 precursor
CD79B at chr17:63928740-63932331 - (NM_000626) B-cell antigen receptor complex-associated protein beta chain isoform 1 precursor
CD79B at chr17:63928740-63932331 - (NM_001039933) B-cell antigen receptor complex-associated protein beta chain isoform 3 precursor
CD70 at chr19:6585839-6591150 - (NM_001252) CD70 antigen isoform 1
CD70 at chr19:6581648-6591150 - (NM_001330332) CD70 antigen isoform 2
CD7 at chr17:82314873-82317608 - (NM_006137) T-cell antigen CD7 precursor
CD72 at chr9:35609982-35618413 - (NM_001782) B-cell differentiation antigen CD72

NCBI RefSeq genes, curated subset (NM_*, NR_*, NP_* or YP_*)

CD79b molecule, transcript variant 2 at chr17:63928736-63932354 - (NM_021602.3)
CD7 molecule at chr17:82314870-82317604 - (NM_006137.6)
CD79a molecule, transcript variant 1 at chr19:41877120-41881372 - (NM_001783.3)
CD70 molecule, transcript variant 2 at chr19:6581646-6591152 - (NM_001330332.1)
CD70 molecule, transcript variant 1 at chr19:6585839-6591152 - (NM_001252.4)
CD74 molecule, transcript variant 1 at chr5:150401637-150412936 - (NM_001025159.2)
CD79b molecule, transcript variant 1 at chr17:63928736-63932354 - (NM_000626.3)
CD74 molecule, transcript variant 3 at chr5:150401637-150412936 - (NM_001025158.2)
CD79b molecule, transcript variant 3 at chr17:63928736-63932354 - (NM_001039933.2)
CD79b molecule, transcript variant 4 at chr17:63928736-63932354 - (NM_001329050.1)
CD72 molecule at chr9:35609979-35618427 - (NM_001782.2)
CD74 molecule, transcript variant 2 at chr5:150401637-150412936 - (NM_004355.3)
CD79a molecule, transcript variant 2 at chr19:41877120-41881372 - (NM_021601.3)
immunoglobulin (CD79A) binding protein 1 pseudogene 1 at chr14:34939922-34940496 - (NR_002937.2)

NCBI RefSeq genes, predicted subset (XM_* or XR_*)

CD7 molecule, transcript variant X2 at chr17:82314865-82320829 - (XR_001752681.1)
CD7 molecule, transcript variant X3 at chr17:82314865-82317579 - (XM_017025316.1)
CD74 molecule, transcript variant X2 at chr5:150401637-150412756 - (XM_017010089.2)
CD72 molecule, transcript variant X1 at chr9:35609981-35618427 - (XM_006716893.2)
CD7 molecule, transcript variant X4 at chr17:82314865-82317541 - (XM_011523608.1)
CD74 molecule, transcript variant X3 at chr5:150401637-150412756 - (XM_017010090.2)
CD7 molecule, transcript variant X1 at chr17:82316385-82320829 - (XR_001752680.1)
CD74 molecule, transcript variant X1 at chr5:150401637-150412756 - (XR_002956198.1)

Non-Human RefSeq Genes

CD74 at chr5:150401639-150412751 - (NM_001144836) HLA class II histocompatibility antigen gamma chain
CD74 at chr5:150401683-150412702 - (NM_001034735) HLA class II histocompatibility antigen gamma chain
CD74 at chr5:150401693-150407323 - (NM_001099770) HLA class II histocompatibility antigen gamma chain
Cd74 at chr5:150401648-150412704 - (NM_013069) H-2 class II histocompatibility antigen gamma chain
Cd74 at chr5:150401654-150412701 - (NM_010545) H-2 class II histocompatibility antigen gamma chain isoform 2
Cd74 at chr5:150401654-150412701 - (NM_001042605) H-2 class II histocompatibility antigen gamma chain isoform 1
CD79A at chr19:41878989-41880980 - (NM_001135962) B-cell antigen receptor complex-associated protein alpha chain precursor
CD79A at chr19:41877282-41881373 - (NM_174266) B-cell antigen receptor complex-associated protein alpha chain precursor
CD79A at chr19:41877302-41881268 - (NM_001313834) B-cell antigen receptor complex-associated protein alpha chain precursor
Cd79a at chr19:41877281-41881345 - (NM_007655) B-cell antigen receptor complex-associated protein alpha chain precursor
CD79B at chr17:63928803-63932352 - (NM_001261525) B-cell antigen receptor complex-associated protein beta chain precursor
CD79B at chr17:63929211-63932261 - (NM_001243912) B-cell antigen receptor complex-associated protein beta chain precursor
Cd79b at chr17:63929030-63932287 - (NM_133533) B-cell antigen receptor complex-associated protein beta chain precursor
Cd79b at chr17:63929030-63932276 - (NM_008339) B-cell antigen receptor complex-associated protein beta chain isoform 1 precursor
Cd79b at chr17:63929030-63932276 - (NM_001313939) B-cell antigen receptor complex-associated protein beta chain isoform 2 precursor
LOC100500766 at chr19:41879091-41880986 - (NM_001195409) CD79a precursor
Cd72 at chr9:35609983-35618321 - (NM_001110320) B-cell differentiation antigen CD72 isoform 1
Cd72 at chr9:35609983-35618321 - (NM_007654) B-cell differentiation antigen CD72 isoform 2
Cd70 at chr19:6586011-6586394 - (NM_011617) CD70 antigen
Cd72 at chr9:35609983-35618321 - (NM_001110321) B-cell differentiation antigen CD72 isoform 3
Cd72 at chr9:35609983-35618321 - (NM_001110322) B-cell differentiation antigen CD72 isoform 4
CD70 at chr19:6586020-6586397 - (NM_001044531) CD70 antigen
Cd7 at chr17:82315321-82316979 - (NM_009854) T-cell antigen CD7 precursor
Cd70 at chr19:6586011-6586403 - (NM_001106878) CD70 antigen
LOC534155 at chrX:70133951-70166130 - (NM_001104988) immunoglobulin (CD79A) binding protein 1-like
CD7 at chr17:82314695-82316983 - (NM_001098922) T-cell antigen CD7 precursor
CD70 at chr19:6586020-6590136 - (NM_001319881) CD70 antigen
CD74 at chr5:150401639-150412751 - (NM_001131158) CD74 molecule
CD7 at chr17:82315308-82316996 - (NM_001009296) T-cell antigen CD7 precursor
Cd7 at chr17:82315321-82316943 - (NM_001107074) T-cell antigen CD7 precursor
Cd72 at chr9:35609982-35618321 - (NM_001015016) B-cell differentiation antigen CD72
CD74 at chr5:150402567-150412701 - (NM_213774) CD74 antigen
nt5e.S at chr6:85450224-85493923 - (NM_001095994) 5'-nucleotidase, ecto (CD73) precursor
igbp1.L at chr4:82401575-82402447 - (NM_001091266) immunoglobulin (CD79A) binding protein 1 L homeolog
CD72 at chr9:35609982-35618303 - (NM_001097493) B-cell differentiation antigen CD72

Basic Gene Annotation Set from GENCODE Version 31 (Ensembl 97)

CD7 at chr17:82314868-82317577
CD7 at chr17:82314873-82317608
CD7 at chr17:82314874-82317552
CD7 at chr17:82315975-82317558

Comprehensive Gene Annotation Set from GENCODE Version 31 (Ensembl 97)

CD7 at chr17:82314868-82317577
CD7 at chr17:82314873-82317608
CD7 at chr17:82314874-82317552
CD7 at chr17:82315975-82317558
CD7 at chr17:82316132-82317553
CD7 at chr17:82316220-82317550
CD7 at chr17:82316385-82317579

Basic Gene Annotation Set from GENCODE Version 29 (Ensembl 94)

CD7 at chr17:82314868-82317577
CD7 at chr17:82314870-82317602
CD7 at chr17:82314874-82317552
CD7 at chr17:82315975-82317558

Comprehensive Gene Annotation Set from GENCODE Version 29 (Ensembl 94)

CD7 at chr17:82314868-82317577
CD7 at chr17:82314870-82317602
CD7 at chr17:82314874-82317552
CD7 at chr17:82315975-82317558
CD7 at chr17:82316132-82317553
CD7 at chr17:82316220-82317550
CD7 at chr17:82316385-82317579

Basic Gene Annotation Set from GENCODE Version 28 (Ensembl 92)

CD7 at chr17:82314868-82317577
CD7 at chr17:82314870-82317602
CD7 at chr17:82314874-82317552
CD7 at chr17:82315975-82317558

Comprehensive Gene Annotation Set from GENCODE Version 28 (Ensembl 92)

CD7 at chr17:82314868-82317577
CD7 at chr17:82314870-82317602
CD7 at chr17:82314874-82317552
CD7 at chr17:82315975-82317558
CD7 at chr17:82316132-82317553
CD7 at chr17:82316220-82317550
CD7 at chr17:82316385-82317579

Basic Gene Annotation Set from GENCODE Version 27 (Ensembl 90)

CD7 at chr17:82314868-82317577
CD7 at chr17:82314870-82317602
CD7 at chr17:82314874-82317552
CD7 at chr17:82315975-82317558

Comprehensive Gene Annotation Set from GENCODE Version 27 (Ensembl 90)

CD7 at chr17:82314868-82317577
CD7 at chr17:82314870-82317602
CD7 at chr17:82314874-82317552
CD7 at chr17:82315975-82317558
CD7 at chr17:82316132-82317553
CD7 at chr17:82316220-82317550
CD7 at chr17:82316385-82317579

Basic Gene Annotation Set from GENCODE Version 26 (Ensembl 88)

CD7 at chr17:82314868-82317577
CD7 at chr17:82314870-82317602
CD7 at chr17:82314874-82317552
CD7 at chr17:82315975-82317558

Comprehensive Gene Annotation Set from GENCODE Version 26 (Ensembl 88)

CD7 at chr17:82314868-82317577
CD7 at chr17:82314870-82317602
CD7 at chr17:82314874-82317552
CD7 at chr17:82315975-82317558
CD7 at chr17:82316132-82317553
CD7 at chr17:82316220-82317550
CD7 at chr17:82316385-82317579

Basic Gene Annotation Set from GENCODE Version 25 (Ensembl 85)

CD7 at chr17:82314868-82317577
CD7 at chr17:82314870-82317602
CD7 at chr17:82314874-82317552
CD7 at chr17:82315975-82317558

Comprehensive Gene Annotation Set from GENCODE Version 25 (Ensembl 85)

CD7 at chr17:82314868-82317577
CD7 at chr17:82314870-82317602
CD7 at chr17:82314874-82317552
CD7 at chr17:82315975-82317558
CD7 at chr17:82316132-82317553
CD7 at chr17:82316220-82317550
CD7 at chr17:82316385-82317579

Basic Gene Annotation Set from GENCODE Version 24 (Ensembl 83)

CD7 at chr17:82314868-82317577
CD7 at chr17:82314870-82317602
CD7 at chr17:82314874-82317552
CD7 at chr17:82315975-82317558

Comprehensive Gene Annotation Set from GENCODE Version 24 (Ensembl 83)

CD7 at chr17:82314868-82317577
CD7 at chr17:82314870-82317602
CD7 at chr17:82314874-82317552
CD7 at chr17:82315975-82317558
CD7 at chr17:82316132-82317553
CD7 at chr17:82316220-82317550
CD7 at chr17:82316385-82317579

Basic Gene Annotation Set from GENCODE Version 23 (Ensembl 81)

CD7 at chr17:82314868-82317577
CD7 at chr17:82314870-82317602
CD7 at chr17:82314874-82317552
CD7 at chr17:82315975-82317558

Comprehensive Gene Annotation Set from GENCODE Version 23 (Ensembl 81)

CD7 at chr17:82314868-82317577
CD7 at chr17:82314870-82317602
CD7 at chr17:82314874-82317552
CD7 at chr17:82315975-82317558
CD7 at chr17:82316132-82317553
CD7 at chr17:82316220-82317550
CD7 at chr17:82316385-82317579

Basic Gene Annotation Set from GENCODE Version 22 (Ensembl 79)

CD7 at chr17:82314868-82317577
CD7 at chr17:82314870-82317602
CD7 at chr17:82314874-82317552
CD7 at chr17:82315975-82317558

Comprehensive Gene Annotation Set from GENCODE Version 22 (Ensembl 79)

CD7 at chr17:82314868-82317577
CD7 at chr17:82314870-82317602
CD7 at chr17:82314874-82317552
CD7 at chr17:82315975-82317558
CD7 at chr17:82316132-82317553
CD7 at chr17:82316220-82317550
CD7 at chr17:82316385-82317579

Basic Gene Annotation Set from GENCODE Version 20 (Ensembl 76)

CD7 at chr17:82314868-82317577
CD7 at chr17:82314870-82317602
CD7 at chr17:82314874-82317552
CD7 at chr17:82315975-82317558

Comprehensive Gene Annotation Set from GENCODE Version 20 (Ensembl 76)

CD7 at chr17:82314868-82317577
CD7 at chr17:82314870-82317602
CD7 at chr17:82314874-82317552
CD7 at chr17:82315975-82317558
CD7 at chr17:82316132-82317553
CD7 at chr17:82316220-82317550
CD7 at chr17:82316385-82317579

International Knockout Mouse Consortium Genes Mapped to Human Genome

Cd70_85454 at chr19:6585839-6591152
Cd70_VG11171 at chr19:6585839-6591152
Cd72_41511 at chr9:35609979-35618427
Cd72_51684 at chr9:35609979-35618427
Cd72_94005 at chr9:35609979-35618427
Cd72_VG11569 at chr9:35609979-35618427
Cd74_44660 at chr5:150401637-150412769
Cd79a_24506 at chr19:41877120-41881372
Cd79a_24507 at chr19:41877120-41881372
Cd79b_28582 at chr17:63928738-63932344
Cd79b_VG11679 at chr17:63928738-63932344
Cd7_116564 at chr17:82314870-82317604
Cd7_118280 at chr17:82314870-82317604
Cd7_31825 at chr17:82314870-82317604
Cd7_76448 at chr17:82314870-82317604

Human Aligned mRNA Search Results

X54363 - H.sapiens mRNA for B-cell antigen CD75.
S69339 - surface antigen CD70=type II transmembrane protein [human, EBV-transformed B cell line, JY, mRNA, 888 nt].
EU236945 - Homo sapiens CD74/ROS fusion protein (CD74/ROS fusion) mRNA, complete cds.
DQ174771 - Homo sapiens CD72b (CD72) mRNA, complete cds.
BT019505 - Homo sapiens CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated) mRNA, complete cds.
BT006696 - Homo sapiens CD7 antigen (p41) mRNA, complete cds.
BC113731 - Homo sapiens CD79a molecule, immunoglobulin-associated alpha, mRNA (cDNA clone MGC:142291 IMAGE:8322783), complete cds.
BC113733 - Homo sapiens CD79a molecule, immunoglobulin-associated alpha, mRNA (cDNA clone MGC:142293 IMAGE:8322785), complete cds.
BC030227 - Homo sapiens CD72 molecule, mRNA (cDNA clone MGC:34615 IMAGE:5226648), complete cds.
BC030210 - Homo sapiens CD79b molecule, immunoglobulin-associated beta, mRNA (cDNA clone IMAGE:5209928), complete cds.
BC009293 - Homo sapiens CD7 molecule, mRNA (cDNA clone MGC:16622 IMAGE:4120480), complete cds.
BC013297 - Homo sapiens CD7 molecule, mRNA (cDNA clone MGC:3929 IMAGE:3529600), complete cds.
BC004137 - Homo sapiens immunoglobulin (CD79A) binding protein 1, mRNA (cDNA clone MGC:1556 IMAGE:2962967), complete cds.
BT006736 - Homo sapiens immunoglobulin (CD79A) binding protein 1 mRNA, complete cds.
BC002975 - Homo sapiens CD79b molecule, immunoglobulin-associated beta, mRNA (cDNA clone MGC:2173 IMAGE:3542354), complete cds.
BC032651 - Homo sapiens CD79b molecule, immunoglobulin-associated beta, mRNA (cDNA clone MGC:45004 IMAGE:5504755), complete cds.
BC000725 - Homo sapiens CD70 molecule, mRNA (cDNA clone MGC:1597 IMAGE:3506629), complete cds.
AY935534 - Homo sapiens clone 18 CD7 antigen mRNA, complete cds.
AY935535 - Homo sapiens clone 14 CD7 antigen mRNA, complete cds.
AY935536 - Homo sapiens clone 32 CD7 antigen mRNA, complete cds.
AY935537 - Homo sapiens clone 5240 CD7 antigen mRNA, complete cds.
AB795245 - Homo sapiens CD74-ROS1_C6;R34 mRNA for CD74-ROS1_C6;R34 fusion protein, complete cds.
AB795244 - Homo sapiens CD74-ROS1_C6;R32 mRNA for CD74-ROS1_C6;R32 fusion protein, complete cds.
AB209587 - Homo sapiens mRNA for CD72 antigen variant protein.
AK223465 - Homo sapiens mRNA for CD7 antigen precursor variant, clone: FCC117E08.
AK223371 - Homo sapiens mRNA for CD79A antigen isoform 1 precursor variant, clone: FCC103G02.
AK222954 - Homo sapiens mRNA for CD79B antigen isoform 1 precursor variant, clone: HSI00794.
AK223210 - Homo sapiens mRNA for CD79B antigen isoform 1 precursor variant, clone: SPL04753.
AF283770 - Homo sapiens clone TCBAP0759 mRNA sequence.
AB037883 - Homo sapiens mRNA for Gb3/CD77 synthase, complete cds.
BC065937 - Homo sapiens 5'-nucleotidase, ecto (CD73), mRNA (cDNA clone MGC:75146 IMAGE:6163101), complete cds.
S79249 - Ig-beta/B29=CD79b {alternatively spliced} [human, B cells, mRNA Partial, 375 nt].
S79248 - Ig-alpha/mb-1=CD79a {alternatively spliced} [human, B cells, mRNA Partial, 564 nt].
BC018726 - Homo sapiens CD74 molecule, major histocompatibility complex, class II invariant chain, mRNA (cDNA clone MGC:31825 IMAGE:4853578), complete cds.
BC024272 - Homo sapiens CD74 molecule, major histocompatibility complex, class II invariant chain, mRNA (cDNA clone MGC:39144 IMAGE:4763768), complete cds.
KF724385 - Homo sapiens MHC class II invariant chain/neurotrophic tyrosine kinase receptor type 1 fusion protein (CD74-NTRK1 fusion) mRNA, complete cds.
Y10204 - H.sapiens mRNA for CD77 protein.
Y10203 - H.sapiens mRNA for CD75 protein.
X06180 - Human mRNA for CD7 antigen (gp40).
CR456782 - Homo sapiens full open reading frame cDNA clone RZPDo834G014D for gene IGBP1, immunoglobulin (CD79A) binding protein 1; complete cds, incl. stopcodon.
BC015940 - Homo sapiens 5'-nucleotidase, ecto (CD73), mRNA (cDNA clone IMAGE:3920680), complete cds.
BC011734 - Homo sapiens CD72 molecule, mRNA (cDNA clone IMAGE:4336217).
BC001188 - Homo sapiens transferrin receptor (p90, CD71), mRNA (cDNA clone MGC:3151 IMAGE:3354176), complete cds.
AK300669 - Homo sapiens cDNA FLJ54063 complete cds, highly similar to Homo sapiens CD74 antigen, transcript variant 2, mRNA.
AK298096 - Homo sapiens cDNA FLJ57491 complete cds, moderately similar to T-cell antigen CD7 precursor.
AK292076 - Homo sapiens cDNA FLJ75773 complete cds, highly similar to Homo sapiens CD74 antigen (invariant polypeptide of majorhistocompatibility complex, class II antigen-associated) (CD74),mRNA.
AK291723 - Homo sapiens cDNA FLJ75881 complete cds, highly similar to Homo sapiens transferrin receptor (p90, CD71) (TFRC), mRNA.
AK315660 - Homo sapiens cDNA, FLJ96752, highly similar to Homo sapiens immunoglobulin (CD79A) binding protein 1 (IGBP1),mRNA.
AK315337 - Homo sapiens cDNA, FLJ96378, Homo sapiens CD79A antigen (immunoglobulin-associated alpha)(CD79A), transcript variant 1, mRNA.
AK314661 - Homo sapiens cDNA, FLJ95508, highly similar to Homo sapiens 5'-nucleotidase, ecto (CD73) (NT5E), mRNA.
AK313583 - Homo sapiens cDNA, FLJ94147, highly similar to Homo sapiens CD79B antigen (immunoglobulin-associated beta) (CD79B), transcript variant 1, mRNA.

Human Unaligned mRNA Search Results

NR_157074 - Homo sapiens CD74 molecule (CD74), transcript variant 6, non-coding RNA.
NR_002937 - Homo sapiens immunoglobulin (CD79A) binding protein 1 pseudogene 1 (IGBP1P1), non-coding RNA.